CVS keeps talking up healthcare services, but insurance costs + PBM risk are weighing it down. Analyst targets don’t show much upside. Cheap buy or dead money?
There are no replies in this thread yet. Be the first to post a reply below:
CVS keeps talking up healthcare services, but insurance costs + PBM risk are weighing it down. Analyst targets don’t show much upside. Cheap buy or dead money?
There are no replies in this thread yet. Be the first to post a reply below: